List of Literature
about Patient Compliance

Dr. Bates, Andree: Ensuring Profitable Patient Adherence Programs, using Analytics and Metrics to Improve the Bottom Line. March 2008. www.patientadherenceroi.com

Packaging´s role in posion prevention / Study reveals packaging´s impact on hypertension - July 2005 issue                                              http://www.healthcare-packaging.com

Allen, Daphne: Enhancing Your Unit Doses. http://devicelink.com/pmpn/archive/05/02/022.html

American Medical Association: Knowledge is the best Medicine. American Medical News, July 2000

Arnet I., Schoenenberger R.A., Spiegel R., Haefeli W.E.: Überzeugung als Fundament der Compliance und Techniken zur Compliance-Optimierung. Schweiz Med. Wochenschr. 1999; 129:1477-86

Bangsberg D.R. et al. as quoted in: WHO Report: Adherence to long-term therapies; evidence for action 2003

Bauman A.E., Craig A.R., Dunsmore J, Browne G., Allen D.H., Vandenberg R.: Removing Barriers to Effective Self-Management of Asthma. Patient Education and Counselling. 14:217-226. 1989

Beardon P.H.G. et al.: Primary non compliance with prescribed medication in primary care. Br. Med. J. 307, 1993

Berg et al., Medication Compliance: A Healthcare Problem. The Annals of Pharmacotherapy 1993

Bloom B.S.: The Medical, Social, and Economic Implications of Disease. In:W van Eimeren and B. Horisberger eds.: Socioeconomic Evaluation of Drug Therapy. Springer Verlag 1988

Clark L.T.: Improving Comliance and Increasing Control of Hypertension: Needs of Special Hypertensive Populations. American Heart Journal. 664-669 1991

Coambs Robert B., et al : Consequences and Health Costs of Noncompliance & Inapppropriate Use of Prescription Medication in Canada. Review of the Scientific Literature of the Prevalence, 1995

Dlugi Peter/Ost Dietwald: Kindersichere Verpackungen. Pharmind 58,3 251-255 (1996)

Ernst F.R., Grizzle A.J.: Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model. Journal of the American Pharmaceutical Association, March/April 2001

Haynes R.B.: Determinants of compliance: the disease and the mechanics of treatment. In: Haynes R.B., Taylor D.W, Sackett D.L., eds: Compliance in Health Care. John Hopkins University Press 1979

Haynes R.B. et al.: Interventions for helping patients follow prescriptions for medications. Cochrane Database of Systematic Reviews. 2001

Heilmann Klaus: Das Risiko der Sicherheit. 3-7776-1148-4

Hemminki E., Brambilla D.J., McKinlay S.M., PosnerJ.G.: Use of Estrogens Among Middle- Aged Massachusetts Women. DICP: The Annals of Pharmacotherapy 25: 418-423. 1991

Heuer H.O., Heuer S., Lenneke K.: Ursachen der Non-Compliance; Compliance in der Arzneitherapie. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart. 1999

Joglekar M., Mohnaruban K., Bayer A.J., Pathy M.S.J.: Can Old People on Oral Anticoagulants be Safely Managed as Out-patients? Postgraduate Medical Journal. 64(756):775-777. 1988

Johnson, J.A.and Bootman, J.L.: Drug-Related Morbidity and Mortality and the Economic Impact of Pharmaceutical Care. American Journal of Health-System Pharmacy AJHP 54.5, 1997

Jones E.F., ForrestJ.D.: Contrceptive Failure Rates Based on the 1988 NSFG. Family Planning Perspectives. 24(1): 12-19. 1992

Korab Tassilo: Child-Resistant Blister Packs. http://www.samedanltd.com

Korab Tassilo: New Standards for CR Reclosable Packaging of Pharmaceutical Products. http://www.teich.com

Leonard W.G., Leonard D.: Calendar oriented compliance. Maturitas, the international journal for the study of the climacteric. Sept. 1984

Leppik I.E.: How to get patients with epilepsy to take their medication. The problem of non-compliance. Postgraduate Medicine 88:253-256 1990

Levy R.A.: Failure to refill prescriptions. Incidence, reasons, and remidies. In: Patient Compliance in Medical Practice and Clinical Trials (Cramer J.A., Spilker B. Eds) Raven Press 1991

Martineau William. World Pharmaceutical Packaging Prod. Demand. http://www.samedanltd.com

Montaner J.S.G. et al. : A randomised, double blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Journal of the American Medical Association, 1998

Murray M.D., Birt J.A., Manatunga A.K., Darnell J.C.: The annuals of Pharmaco Therapy, Vol 23, May1993

Mühlig S.: Das Compliance Problem. Deutsche Apotheker Ztg.138(14) 1998

Nagasawa M., Smith B.C., Barnes J.H.,: Meta-Analysis of Correlates of Diabetes Patients’ Compliance With Prescribed Medications. The Diabetes Educator. 16(3) 192-200 1989

National Audit Office Survey; Safety, quality, efficacy: regulating medicine in UK. Audit Commissions Report on Medicines Control Agency 2003.
http://www.nao.org.uk/publications/0203/safety,_quality,_efficacy_reg.aspx

National Prescriptions Buyer Survey 1985

NCPIE. Prescription Medicine Compliance: “A review of the Baseline of Knowledge” 1995 NCPIE, www.talkaboutrx.org/compliance.html

Nikolaus, Krause, Bacj, Specht-Leible, Oster, Schlierf;
European Journal of Clinical Pharmacy, 1996

Playle J., Keeley P.,: Non Compliance and Professional Power. Journal of Advanced Nursing Vol.27, Issue 2,  Fe. 1998. Blackwell Publishing

Powell B.J., Penic E.C., Liskow B.I., Rice A.S., McKnelly W.: Lithium Compliance in Alcoholic Males.: A Six Month Follow Up Study. Addictive Behaviours. 11:135-140. 1986

Rovelli M., Palmeri D., Vossler E., Bartus S., Hull D., Schweizer R.: Non-
compliance in Organ Transplant Recipients. Transplantation Proceedings. 21:833-834. 1989

Rudd P.: Compliance with antihypertensive therapy: a shifting paradigm. Cardiol. Rev. 2(5) 1994

Sackett D.L., Snow J.C.: The magnitude of compliance and noncompliance. In:
Haynes R.B. et al.: Compliance in Health care. John Hopkins University Press 1979

Scrabaneck P., McCormick J.: Torheiten und Trugschlüsse in der Medizin, Verlag Kirchheim Mainz 1991 as quoted in Heuer H.O., Heuer S., Lenneke K.: Compliance in der Medizintherapie, Wissenschaftliche Verlagsgesellschaft mbH. Stuttgart 1999

Spilker B.: Methods of assessing and improving patient compliance in clinical trials. In: Patient Compliance in Medical Practice and Clinical Trials (Cramer J.A., Spliker B, eds) Raven Press 1991

Sulz H.A., Young K.M.: Healthcare USA,
http: publichealth.jbpub.com/healthcareusa fourth edition, Chapter 7
 
Task Force for Compliance Report, November 1993, Revised April 1994

Vetter W. Prof. Dr.: Das Auge schluckt mit. Schweiz. Rundschau Med. (Praxis) 75, Nr.45 1986

Wilkins Stephen: Progress towards CR Flexible Packs for Pharmaceuticals in the U.K. an ROEurope. http://www.samedanltd.com/

Woodburn, Connie R.: Medication Errors and Pharmaceutical Packaging. http://www.cardinal.com/

World Health Organisation Infectious disease report. Publication Code: WHO CDS99.1, 1999

World Health Organisation Report. Adherence to long-term therapies: evidence for action. 2003

http://www.unitdose.org/

http://www.pecmi.org/

http://www.patientpacks.com/

v.d.Gathen H.: Jede Kette ist so stark, wie ihr schwächstes Glied – Complianceförderung durch den Apotheker. PZ Prisma 4 1997

Ware G.J., Holford N.H., Davison J.G., Harris R.G.: Unit dose Calender Packaging and Elderly Patient Compliance. NZ Med. Jrnl. 104: 495-497. 1991